Zhang, Y., Zahra, F. T., DeAvila, D., Shah, B., Gaballa, S., Bello, C., Saeed, H., Mirza, A., Isenalumhe, L., Puglianini, O. A. C., Lazaryan, A., Sokol, L., Locke, F., Jain, M., Thompson, Z., Pinilla-Ibarz, J., Chavez, J. (2025). Real-world efficacy outcomes of epcoritamab and glofitamab in Relapsed/Refractory aggressive B-cell lymphoma: A single-center cohort emphasizing trial-ineligible populations. Blood. https://doi.org/10.1182/blood-2025-2767